Crossmark

Dose-individualization Efficiently Maintains Sufficient Exposure to Methotrexate without Additional Toxicity in High-dose Methotrexate Regimens for Pediatric Acute Lymphoblastic Leukemia

Crossref DOI link: https://doi.org/10.1007/s11596-022-2589-1

Published Online: 2022-07-21

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shen, Ya-qing

Wang, Zhu-jun

Wu, Xiao-yan

Li, Kun

Wang, Zhong-jian

Xu, Wen-fu

Zhou, Fen

Jin, Run-ming
License Information

Text and Data Mining valid from 2022-07-21

Version of Record valid from 2022-07-21
More Information

Article History

Received: 19 August 2021

Accepted: 11 December 2021

First Online: 21 July 2022

Conflict of Interest Statement

: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

: Author Run-ming JIN is a member of the Editorial Board for Current Medical Science. Author Fen ZHOU is a member of Youth Editorial Committee for Current Medical Science. The paper was handled by other editors and has undergone rigorous peer review process. Authors Run-ming JIN and Fen ZHOU were not involved in the journal’s review of, or decisions related to, this manuscript.

Document is current

Any future updates will be listed below